• Products
  • Suppliers
  • Sourcing Requests
  • capsule
  • Paracetamol
  • Dexamethasone
  • semaglutide
  • peptides
  • Metformin
  • Ritonavir
  • liraglutide
  • Yaan Times Biotech Co., Ltd
  • Changsha Staherb Natural Ingredients Co., Ltd.
  • PURELIFE BIOTECH CO.,LTD.
  • Biocompounds Pharmaceutical Inc.
  • Xi'an Kaixiang Photoelectric Technology Co., Ltd
  • Apollo Healthcare Resources (Singapore)
  • Shanghai UFU Laboratory Equipment Co.,Itd
  • GN Chemicals CO,Ltd.
Post Sourcing Request Exhibition
  • Farxiga Meets Primary Endpoint in Heart Failure Trial americanpharmaceuticalreview
    August 21, 2019
    AstraZeneca has announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpoint with a statistically-significant and clinically-meaningful reduction of ...
  • Entresto tops mainstay ACE inhibitor in heart failure trial pharmaphorum
    December 04, 2018

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service